An editorial that accompanied the study cautioned that it is unclear if recovered patients’ antibodies will protect them from reinfection.
However, it suggested that antibody tests may be a cost-effective alternative to infection testing alone, and may work better in surveying populations as countries look to safely reopen their economies and schools.